Table 1 CAV3 mutations identified in patients affected by LGMD-1C
From: Caveolinopathies: from the biology of caveolin-3 to human diseases
Nt. change | Aa. change | Phenotype | Ref. |
|---|---|---|---|
N-terminal domain | |||
c.77G>A | p.R26Q | LGMD | Figarella Branger et al57 |
c.77G>A | p.R26Q | LGMD, RMD | Fee et al60 |
c.81C>A | p.D27E | LGMD, RMD, DM | Fischer et al61 |
c.96C>G | p.N32K | LGMD | Sugie et al58 |
c.114+2T>C* | p.K37X | LGMD | Muller et al44 |
c.128T>A | p.V43E | LGMD | Sugie et al58 |
c.133G>A | p.A45T | LGMD | Herrmann et al12 |
c.163G>A* | p.G55S | LGMD | McNally et al42 |
Scaffolding domain | |||
c.183C>A | p.S60R | LGMD,H-CK | Fulizio et al48 |
c.187A>C | p.T63P | LGMD | Matsuda et al56 |
c.187_194del | p.TFT63-65del | LGMD | Minetti et al54 |
c.216C>G | p.C71W | LGMD | McNally et al42 |
Membrane-spanning domain | |||
c.233C>T* | p.T77M | LGMD | Traverso et al47 |
c.277G>A* | p.A92T | LGMD- RMD | Kubisch et al43 |
c.290_293del | p.F96del | LGMD, RMD, H-CK | Cagliani et al78 |
c.314C>T | p.P104 L | LGMD | Minetti et al54 |